News|Articles|July 3, 2025
Q2 2025 Recap: Hepatology News and Updates
Author(s)Abigail Brooks, MA
Fact checked by: Chelsie Derman
The Q2 recap for hepatology spotlights regulatory approvals, clinical trial updates, and the launch of HCPLive’s flagship hepatology podcast.
Advertisement
Advertisement
The second quarter of 2025 delivered a wave of meaningful developments in hepatology—from FDA approvals that expand therapeutic options to promising pipeline data that could shape the future of care across a spectrum of liver diseases and the launch of a new hepatology podcast hosted by some of the field’s leading experts.
Advertisement
Advertisement